Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Biocon Limited (NSE: BIOCON), ISIN INE376G01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BIOCON last traded at ₹393.85 (-0.08%), with a 52-week range of ₹337.20 to ₹447.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 44.68%, FIIs 8.14%, DIIs 23.38%, mutual funds 15.47%.
EquiSense Score (ECS): 74/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.